Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,481,667
+$8,218,215 QoQ
Shares Held
23,746
+7.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
4.12%
of 13F equity value
Holder Rank
#738
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026COZAD ASSET MANAGEMENT INC holds $35,468,302 across 7 Drug Manufacturers - General names. LLY ranks #1 (80.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
23,746 | $28,481,667 | |
| 2 | JNJ |
Johnson & Johnson
|
17,475 | $4,438,125 | |
| 3 | PFE |
Pfizer Inc
|
35,997 | $866,807 | |
| 4 | AMGN |
Amgen Inc
|
1,667 | $603,654 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,012 | $506,876 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,019 | $346,814 | |
| 7 | NVO |
Novo Nordisk A S
|
4,680 | $224,359 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,481,667 | 23,746 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $20,263,452 | 22,031 | Shares | Sole | 2026-05-28 | |
| 2025-12-31 | $23,190,521 | 21,579 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,134,691 | 22,457 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $16,911,903 | 21,695 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $16,572,710 | 20,066 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $14,747,516 | 19,103 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $16,005,392 | 18,066 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $14,371,096 | 15,873 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $7,711,917 | 9,913 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,812,298 | 3,109 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,772,529 | 3,300 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $1,547,634 | 3,300 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,174,496 | 3,420 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $1,251,172 | 3,420 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $908,290 | 2,809 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $917,246 | 2,829 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $804,413 | 2,809 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $487,252 | 1,764 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $472,035 | 2,043 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $468,909 | 2,043 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $381,673 | 2,043 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $304,418 | 1,803 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $266,880 | 1,803 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $276,314 | 1,683 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $233,465 | 1,683 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||